Higher vagal activity as related to survival in patients with advanced breast cancer: An analysis of autonomic dysregulation

Psychosomatic Medicine

Volumn 77, Issue 4, 2015, Pages 346-355

  Giese Davis, Janine ^a,b,c   Wilhelm, Frank H ^d   Tamagawa, Rie ^a,b   Palesh, Oxana ^c   Neri, Eric ^c   Taylor, Craig Barr ^c   Kraemer, Helena C ^c   Spiegel, David ^c  

^a UNIVERSITY OF CALGARY   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Breast cancer; Cancer survival; Heart rate variability; Immune system; Parasympathetic nervous system; Respiratory sinus arrhythmia

Indexed keywords

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; BREAST CANCER; CANCER MORTALITY; CANCER SURVIVAL; CHOLINERGIC SYSTEM; DEPRESSION; FEMALE; FOLLOW UP; HEART INFARCTION; HEART RATE; HEART RATE VARIABILITY; HIGH FREQUENCY HEART RATE VARIABILITY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MIDDLE AGED; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RESTING METABOLIC RATE; SECONDARY ANALYSIS; SPECTROMETRY; SURVIVAL PREDICTION; TASK PERFORMANCE; VAGUS NERVE STIMULATION; AGED; AUTONOMIC NERVOUS SYSTEM; BREAST TUMOR; METASTASIS; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL ANALYSIS; TUMOR RECURRENCE; VAGUS NERVE;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; SURVIVAL ANALYSIS; VAGUS NERVE;

EID: 84924203178     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000167     Document Type: Article

References (106)

1. Giese-Davis J, Wilhelm FH, Conrad A, Abercrombie HC, Sephton S, Yutsis M, Neri E, Taylor CB, Kraemer HC, Spiegel D. Depression and stress reactivity in metastatic breast cancer. Psychosom Med 2006;68:675-83.
2. Gidron Y, Perry H, Glennie M. Does the vagus nerve inform the brain about preclinical tumours and modulate them? Lancet Oncol 2005;6:245-8.
3. Gidron Y, Ronson A. Psychosocial factors, biological mediators, and cancer prognosis: a new look at an old story. Curr Opin Oncol 2008;20:386-92.
4. Mravec B, Gidron Y, Kukanova B, Bizik J, Kiss A, Hulin I. Neural-endocrine-immune complex in the central modulation of tumorigenesis: facts, assumptions, and hypotheses. J Neuroimmunol 2006;180:104-16.
5. Golan H, Kennedy JA, Frenkel A, Parmet Y, Feintuch A, Levi O, Gidron Y. Brain mapping of patients with lung cancer and controls: inquiry into tumor-to-brain communication. J Nucl Med 2009;50:1072-5.
6. Olofsson P, Rosas Ballina M, Levine Y, Tracey K. Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev 2012;248:188-204.
7. Tracey K. The inflammatory reflex. Nature 2002;420:853-9.
8. Tonhajzerova I, Mokra D, Visnovcova Z. Vagal function indexed by respiratory sinus arrhythmia and cholinergic anti-inflammatory pathway. Respir Physiol Neurobiol 2013;187:78-81.
9. Mravec B, Gidron Y, Hulin I. Neurobiology of cancer: interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain. Semin Cancer Biol 2008;18:150-63.
10. Mravec B, Ondicova K, Valaskova Z, Gidron Y, Hulin I. Neurobiological principles in the etiopathogenesis of disease: when diseases have a head. Med Sci Monit 2009;15:RA6-16.
11. De Couck M, Mravec B, Gidron Y. You may need the vagus nerve to understand pathophysiology and to treat diseases. Clin Sci 2012;122:323-8.
12. Huston JM, Tracey KJ. The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med 2011;269:45-53.
13. Rosas-Ballina M, Tracey K. The neurology of the immune system: neural reflexes regulate immunity. Neuron 2009;64:28-32.
14. Berntson GG, Bigger JT Jr, Eckberg DL, Grossman P, Kaufmann PG, Malik M, Nagaraja HN, Porges SW, Saul JP, Stone PH, van der Molen MW. Heart rate variability: origins, methods, and interpretive caveats. Psychophysiology 1997;34:623-48.
15. Thayer J, Sternberg E. Beyond heart rate variability: vagal regulation of allostatic systems. Ann N Y Acad Sci 2006;1088:361-72.
16. Buccelletti E, Gilardi E, Scaini E, Galiuto L, Persiani R, Biondi A, Basile F, Silveri NG. Heart rate variability and myocardial infarction: systematic literature review and metaanalysis. Eur Rev Med Pharmacol Sci 2009;13:299-307.
17. Karp E, Shiyovich A, Zahger D, Gilutz H, Grosbard A, Katz A. Ultra-short-term heart rate variability for early risk stratification following acute ST-elevation myocardial infarction. Cardiology 2009;114:275-83.
18. Carney R, Blumenthal J, Stein P, Watkins L, Catellier D, Berkman L, Czajkowski S, O'Connor C, Stone P, Freedland K. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001;104:2024-8.
19. Riordan WP, Norris PR, Jenkins JM, Morris JA. Early loss of heart rate complexity predicts mortality regardless of mechanism, anatomic location, or severity of injury in 2178 trauma patients. J Surg Res 2009;181:106-13.
20. Kogan A, Allen JJB, Weihs K. Cardiac vagal control as a prospective predictor of anxiety in women diagnosed with breast cancer. Biol Psychol 2012;90:105-11.
21. Fagundes C, Murray D, Hwang B, Gouin J-P, Thayer J, Sollers J, Shapiro C, Malarkey W, Kiecolt Glaser J. Sympathetic and parasympathetic activity in cancer-related fatigue: more evidence for a physiological substrate in cancer survivors. Psychoneuroendocrinology 2011;36:1137-47.
22. Karvinen K, Murray N, Arastu H, Allison R. Stress reactivity, health behaviors, and compliance to medical care in breast cancer survivors. Oncol Nurs Forum 2013;40:149-56.
23. Chiang J-K, Koo M, Kuo TBJ, Fu C-H. Association between cardiovascular autonomic functions and time to death in patients with terminal hepatocellular carcinoma. J Pain Symptom Manage 2010;39:673-9.
24. Kim D, Kim J, Choi Y, Kim S, Lee J, Kim Y. Heart rate variability and length of survival in hospice cancer patients. J Korean Med Sci 2010;25:1140-5.
25. Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M, Moreau M, Nogaret J-M, Hendlisz A, Gidron Y. The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer. Auton Neurosci 2012;166:96-9.
26. De Couck M, van Brummelen D, Schallier D, De Grève J, Gidron Y. The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients. Oncol Rep 2013;30:2435-41.
27. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. Am J Epidemiol 1997;145:899-908.
28. Palesh O, Aldridge-Gerry A, Zeitzer JM, Koopman C, Neri E, Giese-Davis J, Jo B, Kraemer HC, Nouriani B, Spiegel D. Actigraphy measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep 2014;37:837-42.
29. Bernik TR, Friedman SG, Ochani M, DiRaimo R, Ulloa L, Yang H, Sudan S, Czura CJ, Ivanova SM, Tracey KJ. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002;195:781-8.
30. Lehrer P, Karavidas M, Lu S-E, Coyle S, Oikawa L, Macor M, Calvano S, Lowry S. Voluntarily produced increases in heart rate variability modulate autonomic effects of endotoxin induced systemic inflammation: an exploratory study. Appl Psychophysiol Biofeedback 2010;35:303-15.
31. Karavidas M, Lehrer P, Vaschillo E, Vaschillo B, Marin H, Buyske S, Malinovsky I, Radvanski D, Hassett A. Preliminary results of an open label study of heart rate variability biofeedback for the treatment of major depression. Appl Psychophysiol Biofeedback 2007;32:19-30.
32. Lehrer PM, Vaschillo E, Vaschillo B, Lu SE, Scardella A, Siddique M, Habib RH. Biofeedback treatment for asthma. Chest 2004;126:352-61.
33. Niederer D, Vogt L, Thiel C, Schmidt K, Bernhorster M, Lungwitz A, Jager E, Banzer W. Exercise effects on HRV in cancer patients. Int J Sports Med 2013;34:68-73.
34. Iellamo F, Manzi V, Caminiti G, Sposato B, Massaro M, Cerrito A, Rosano G, Volterrani M. Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure. Int J Cardiol 2011;166:334-9.
35. Earnest C, Blair S, Church T. Heart rate variability and exercise in aging women. J Womens Health 2012;21:334-9.
36. Palesh O, Zeitzer JM, Conrad A, Giese-Davis J, Mustian KM, Popek V, Nga K, Spiegel D. Vagal regulation, cortisol, and sleep disruption in women with metastatic breast cancer. J Clin Sleep Med 2008;4:441-9.
37. Spiegel D, Giese-Davis J, Taylor CB, Kraemer H. Stress sensitivity in metastatic breast cancer: analysis of hypothalamicpituitary-adrenal axis function. Psychoneuroendocrinology 2006;31:1231-44.
38. Kirschbaum C, Pirke KM, Hellhammer DH. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993;28:76-81.
39. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 1996;93:1043-65.
40. Taylor CB, Conrad A, Wilhelm FW, Neri E, DeLorenzo A, Kramer MA, Giese-Davis J, Roth W, Oka R Cooke JP, Kraemer H, Spiegel D. Psychophysiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated CVD risk. Psychosom Med 2006;68:538-46.
41. Wilhelm FH, Grossman P, Roth WT. Analysis of cardiovascular regulation. Biomed Sci Instrum 1999;35:135-40.
42. Welch PD. The use of the fast Fourier transform for the estimation of power spectra: a method based on time averaging over short, modified periodograms. IEEE Trans Audio Electroacoust 1967;15:70-3.
43. Grossman P, Taylor EW. Toward understanding respiratory sinus arrhythmia: relations to cardiac vagal tone, evolution and biobehavioral functions. Biol Psychol 2007;74:263-85.
44. Sidney S, Jacobs DR, Haskell WL, Armstrong MA, Dimicco A, Oberman A, Savage PJ, Slattery ML, Sternfeld B, Van Horn L. Comparison of two methods of assessing physical activity in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Epidemiol 1991;133:1231-45.
45. Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, Paffenbarger RS. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985;121:91-106.
46. Sallis JF, Saelens BE. Assessment of physical activity by self-report: status, limitations, and future directions. Res Q Exerc Sport 2000;71:S1-14.
47. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100.
48. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983;24:385-96.
49. Ware JE Jr., Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
50. Kraemer H, Kiernan M, Essex M, Kupfer D. How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychol 2008;27:S101-8.
51. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001;158:848-56.
52. Chen WL, Tsai TH, Huang CC, Chen JH, Kuo CD. Heart rate variability predicts short-term outcome for successfully resuscitated patients with out-of-hospital cardiac arrest. Resuscitation 2009;80:1114-8.
53. Lanza GA, Cianflone D, Rebuzzi AG, Angeloni G, Sestito A, Ciriello G, La Torre G, Crea F, Maseri A. Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina. Heart 2006;92:1055-63.
54. Norris PR, Canter JA, Jenkins JM, Moore JH, Williams AE, Morris JA. Personalized medicine: genetic variation and loss of physiologic complexity are associated with mortality in 644 trauma patients. Ann Surg 2009;250:524-30.
55. King D, Ogilvie M, Pereira BMT, Chang Y, Manning R, Conner J, Schulman C, McKenney M, Proctor K. Heart rate variability as a triage tool in patients with trauma during prehospital helicopter transport. J Trauma 2009;67:436-40.
56. Leino J, Virtanen M, Kahanen M, Nikus K, Lehtimaki T, Kaabi T, Lehtinen R, Turjanmaa V, Viik J, Nieminen T. Exercise-test-related heart rate variability and mortality: the Finnish Cardiovascular Study. Int J Cardiol 2010;144:154-5.
57. Tsuji H, Venditti FJ, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994;90:878-83.
58. Gidron Y, Kupper N, Kwaijtaal M, Winter J, Denollet J. Vagusbrain communication in atherosclerosis-related inflammation: a neuroimmunomodulation perspective of CAD. Atherosclerosis 2007;195:e1-9.
59. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011;334:101-5.
60. Irwin M, Cole S. Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol 2011;11:625-32.
61. Rosas-Ballina M, Olofsson PS, Ochani M, Valdés-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW, Tracey KJ. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011;334:98-101.
62. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med 2009;265:663-79.
63. Zappala G, McDonald PG, Cole SW. Tumor dormancy and the neuroendocrine system: an undisclosed connection? Cancer Metastasis Rev 2013;32:189-200.
64. Balogh S, Fitzpatrick DF, Hendricks SE, Paige SR. Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacol Bull 1993;29:201-6.
65. Dalack GW, Roose SP. Perspectives on the relationship between cardiovascular disease and affective disorder. J Clin Psychiatry 1990;51:S4-9.
66. Porges SW. Emotion: an evolutionary by-product of the neural regulation of the autonomic nervous system. Ann N Y Acad Sci 1997;807:62-77.
67. Thayer JF, Ahs F, Fredrikson M, Sollers JJ 3rd, Wager TD. A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neurosci Biobehav Rev 2012;36:747-56.
68. Lane R, McRae K, Reiman E, Chen K, Ahern G, Thayer J. Neural correlates of heart rate variability during emotion. Neuroimage 2009;44:213-22.
69. Hopp H, Shallcross A, Ford B, Troy A, Wilhelm F, Mauss I. High cardiac vagal control protects against future depressive symptoms under conditions of high social support. Biol Psychol 2013;93:143-9.
70. Wolff B, Wadsworth M, Wilhelm FH, Mauss IB. Children's vagal regulatory capacity predicts attenuated sympathetic stress reactivity in a socially supportive context: evidence for a protective effect of the vagal system. Dev Psychopathol 2012;24:677-89.
71. Weihs KL, Enright TM, Simmens SJ. Close relationships and emotional processing predict decreased mortality in women with breast cancer: preliminary evidence. Psychosom Med 2008;70:117-24.
72. Lutgendorf S, De Geest K, Bender D, Ahmed A, Goodheart M, Dahmoush L, Zimmerman MB, Penedo F, Lucci J, Ganjei Azar P, Thaker P, Mendez L, Lubaroff D, Slavich G, Cole S, Sood A. Social influences on clinical outcomes of patients with ovarian cancer. J Clin Oncol 2012;30:2885-90.
73. Kroenke CH, Kubzansky LD, Schernhammer ES, Holmes MD, Kawachi I. Social networks, social support, and survival after breast cancer diagnosis. J Clin Oncol 2006;24:1105-11.
74. Giese-Davis J, Spiegel D. Emotional expression and cancer progression. In: Davidson RJ, Scherer KR, Hill Goldsmith H, editors. Handbook of Affective Sciences. Oxford: Oxford University Press; 2003:1053-82.
75. DiMatteo MR, Lepper HS, Groghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Int Med 2000;160:2101-7.
76. Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 2011;29:413-20.
77. Sarkar C, Chakroborty D, Basu S. Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines. J Neuroimmune Pharmacol 2013;8:7-14.
78. Fisher A, Newman M. Heart rate and autonomic response to stress after experimental induction of worry versus relaxation in healthy, high-worry, and generalized anxiety disorder individuals. Biol Psychol 2013;93:65-74.
79. Pittig A, Arch JJ, Lam CWR, Craske MG. Heart rate and heart rate variability in panic, social anxiety, obsessive-compulsive, and generalized anxiety disorders at baseline and in response to relaxation and hyperventilation. Int J Psychophysiol 2013;87:19-27.
80. Fernandez C, Pascual J, Soler J, Elices M, Portella M, Fernandez-Abascal E. Physiological responses induced by emotion-eliciting films. Appl Psychophysiol Biofeedback 2012;37:73-9.
81. Murray DR, Irwin M, Rearden CA, Ziegler M, Motulsky H, Maisel AS. Sympathetic and immune interactions during dynamic exercise. Mediation via a beta 2-adrenergic-dependent mechanism. Circulation 1992;86:203-13.
82. Berntson GG, Cacioppo JT, Quigley KS. Cardiac psychophysiology and autonomic space in humans: empirical perspectives and conceptual implications. Psychol Bull 1993;114:296-322.
83. Benschop RJ, Nieuwenhuis EE, Tromp EA, Godaert GL, Ballieux RE, van Doornen LJ. Effects of beta-adrenergic blockade on immunologic and cardiovascular changes induced by mental stress. Circulation 1994;89:762-9.
84. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JMG, Morizono K, Karanikolas BDW, Wu L, Sood AK, Cole SW. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 2010;70:7042-52.
85. Taylor CB. Depression, heart rate related variables and cardiovascular disease. Int J Psychophysiol 2010;78:80-8.
86. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, Stamler J. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1999;149:853-62.
87. Jouven X, Escolano S, Celermajer D, Empana JP, Bingham A, Hermine O, Desnos M, Perier MC, Marijon E, Ducimetiere P. Heart rate and risk of cancer death in healthy men. PloS One 2011;6:e21310.
88. Thomas F, Bean K, Provost JC, Guize L, Benetos A. Combined effects of heart rate and pulse pressure on cardiovascular mortality according to age. J Hypertens 2001;19:863-9.
89. Wannamethee G, Shaper AG, Macfarlane PW. Heart rate, physical activity, and mortality from cancer and other noncardiovascular diseases. Am J Epidemiol 1993;137:735-48.
90. Nilsson PM, Nilsson JA, Hedblad B, Berglund G. Sleep disturbance in association with elevated pulse rate for prediction of mortality-consequences of mental strain? J Intern Med 2001;250:521-9.
91. Kristal-Boneh E, Silber H, Harari G, Froom P. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 2000;21:116-24.
92. Mensink GB, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 1997;18:1404-10.
93. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006;12:939-44.
94. Cole S. Nervous system regulation of the cancer genome. Brain Behav Immun 2013;30:S10-8.
95. Cole SW, Arevalo JMG, Takahashi R, Sloan EK, Lutgendorf SK, Sood AK, Sheridan JF, Seeman TE. Computational identification of gene-social environment interaction at the human IL6 locus. Proc Natl Acad Sci U S A 2010;107:5681-6.
96. Cole S. Social regulation of leukocyte homeostasis: the role of glucocorticoid sensitivity. Brain Behav Immun 2008;22:1049-55.
97. Thayer JF, Fischer JE. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J Intern Med 2009;265:439-47.
98. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363-70.
99. Cohen L, Cole S, Sood A, Prinsloo S, Kirschbaum C, Arevalo JMG, Jennings N, Scott S, Vence L, Wei Q, Kentor D, Radvanyi L, Tannir N, Jonasch E, Tamboli P, Pisters L. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PloS One 2012;7:e42324.
100. Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO, Entschladen F. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 2010;1:628-38.
101. Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: a populationbased study. J Clin Oncol 2011;29:2635-44.
102. Pasquier E, Ciccolini J, Carre M, Giacometti S, Fanciullino R, Pouchy C, Montero MP, Serdjebi C, Kavallaris M, Andre N. Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment. Oncotarget 2011;2:797-809.
103. Thornton L, Andersen B, Carson W. Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis. Cancer Immunol Immunother 2008;57:1471-81.
104. Thornton LM, Andersen BL, Schuler TA, Carson WE, III. A psychological intervention reduces inflammatory markers by alleviating depressive symptoms: secondary analysis of a randomized controlled trial. Psychosom Med 2009;71:715-24.
105. Singh JP, Kandala J, John Camm A. Non-pharmacological modulation of the autonomic tone to treat heart failure. Eur Heart J 2014;35:77-85.
106. Bonaz B, Picq C, Sinniger V, Mayol JF, Clarencon D. Vagus nerve stimulation: from epilepsy to the cholinergic antiinflammatory pathway. Neurogastroenterol Motil 2013;25:208-21.